Wednesday, 16 December 2020: the Interreg INCardio project kicks off. Lead Partner, ICGEB Trieste, together with the EURAC Research, Institute of Biomedicine, Medical University of Innsbruck, and the Carinthia University of Applied Sciences have launched an interregional project to promote European cooperation in cardiovascular research.
The project, which aims to develop and improve cardiovascular research, is led by the ICGEB Cardiovascular Biology laboratory in Trieste and comprises an interregional research consortium that brings together institutes from Italy and Austria.
The research partners comprise of EURAC Research in Bozen, Italy the Medical University of Innsbruck, Austria and the Carinthia University of Applied Sciences CUAS in Klagenfurt, Austria. Associated partners comprise the Cardiology Hospital of Bozen, the Medical Sciences, Surgery and Health division of the University of Trieste and the Cardiology Department of the Hospital of Merano. These institutions have joined under the INCardio project to create a virtual centre for excellence, combining multidisciplinary expertise.
“ICGEB is pleased to start this new project to develop innovative therapies for cardiovascular disease,” said Serena Zacchigna, Project Leader and Head of the ICGEB Cardiovascular Biology lab. “Despite medical advances over the last few decades, cardiovascular diseases remain the major cause of death in the EU and we believe that joining forces and expertise is key to develop innovative therapies and bring them to patients.”
The Cardiovascular Biology lab has established skills in R&I capacities in the field to drive the development of innovative technologies and therapeutic concepts pivotal for this project.
Collectively, the project combines the multidisciplinary expertise to explore the activity of compounds capable of modulating cardiac function.
The Medical University of Innsbruck MUI will be developing training and knowledge exchange methodologies in the fields of ischemia-reperfusion and organ transplantation. EURAC Research will be driving the pilot actions including the search for novel cardioprotective factors and molecules controlling cardiac rhythm, and CUAS will be responsible for the creation of a competence centre and a virtual platform for data exchange. The partnership represents pluriennial experience in Interreg projects. The web site unique to the project is: www.incardio.eu.
The project has received funding for over 1.1 million Euro and will run for two years. INCardio is funded by the ERDF and Interreg V-A Italy-Austria 2014-2020.